Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 3/20 | 0.34 |
| ▸ | ELANE | P08246 | 5/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.32 |
| ▸ | PIP4K2A | P48426 | 1/20 | 0.32 |
| ▸ | SYK | P43405 | 4/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22561687 | 0.87 | MAPT (0.40) | PIK3CAELANESCN9ASYKALOX5 | |
| SCHEMBL22568477 | 0.85 | HDAC3 (0.34) | PIK3CAELANESCN9ASYKALOX5 | |
| SCHEMBL22561758 | 0.82 | SCN9A (0.37) | SCN9AMAPK1 | |
| SCHEMBL22568463 | 0.82 | SCN9A (0.33) | PIK3CAELANESCN9ASYK | |
| SCHEMBL22568474 | 0.82 | SCN9A (0.40) | PIK3CASCN9APIP4K2ASYKALOX5 | |
| SCHEMBL22568395 | 0.81 | PIK3CA (0.35) | PIK3CATHRB | |
| SCHEMBL22568467 | 0.79 | SCN9A (0.42) | ELANESCN9ASYKMAPT | |
| SCHEMBL22568464 | 0.78 | HTR6 (0.40) | ELANE | |
| SCHEMBL22561698 | 0.76 | HDAC8 (0.44) | PIK3CAELANESCN9AALOX5 | |
| SCHEMBL28730199 | 0.75 | ELANE (0.35) | ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230046680-A1 | NOVEL HETEROARYL-SUBSTITUTED AMINOALKYL AZOLE COMPOUNDS AS PESTICIDES | ELANCO ANIMAL HEALTH GMBH (DE) | 2023-02-16 | — | — | US | disclosed |
| WO-2020212235-A1 | NOVEL HETEROARYL-SUBSTITUTED AMINOALKYL AZOLE COMPOUNDS AS PESTICIDES | BAYER ANIMAL HEALTH GMBH (DE) | 2020-10-22 | — | — | WO | disclosed |
| EP-3725788-A1 | NOVEL HETEROARYL-SUBSTITUTED AMINOALKYL AZOLE COMPOUNDS AS PESTICIDES | Bayer AG (DE) | 2020-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230046680-A1 | NOVEL HETEROARYL-SUBSTITUTED AMINOALKYL AZOLE COMPOUNDS AS PESTICIDES | DDT, CRY1, CYP4F3 | PIK3CA 1987/4885ELANE 2180/4885SCN9A 1251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.